221 related articles for article (PubMed ID: 16622953)
1. Genetic engineering regulation in Australia: an 'archaeology' of expertise and power.
Hindmarsh R
Sci Cult (Lond); 2005 Dec; 14(4):373-92. PubMed ID: 16622953
[No Abstract] [Full Text] [Related]
2. Asilomar's legacy in Aotearoa New Zealand.
Rogers-Hayden T
Sci Cult (Lond); 2005 Dec; 14(4):393-410. PubMed ID: 16622954
[No Abstract] [Full Text] [Related]
3. Recombinant regulation: the Asilomar legacy 30 years on.
Hindmarsh R; Gottweis H
Sci Cult (Lond); 2005 Dec; 14(4):299-307. PubMed ID: 16619466
[No Abstract] [Full Text] [Related]
4. The long and winding road from Asilomar to Brussels: science, politics and the public in biotechnology and regulation.
Abels G
Sci Cult (Lond); 2005 Dec; 14(4):339-53. PubMed ID: 16619469
[No Abstract] [Full Text] [Related]
5. Genetically modified survival: red and green biotechnology in Israel.
Prainsack B; Firestine O
Sci Cult (Lond); 2005 Dec; 14(4):355-72. PubMed ID: 16619470
[No Abstract] [Full Text] [Related]
6. From Asilomar to industrial biotechnology: risks, reductionism and regulation.
Krimsky S
Sci Cult (Lond); 2005 Dec; 14(4):309-23. PubMed ID: 16619467
[No Abstract] [Full Text] [Related]
7. Regulation as facilitation: negotiating the genetic revolution.
Black J
Mod Law Rev; 1998 Sep; 61(5):621-60. PubMed ID: 14518446
[No Abstract] [Full Text] [Related]
8. Contemporary science communication as a world of political invention.
Elam M
Sci Cult (Lond); 2004 Jun; 13(2):229-58. PubMed ID: 15988848
[No Abstract] [Full Text] [Related]
9. Transnationalizing recombinant-DNA regulation: between Asilomar, EMBO, the OECD, and the European Community.
Gottweis H
Sci Cult (Lond); 2005 Dec; 14(4):325-38. PubMed ID: 16619468
[No Abstract] [Full Text] [Related]
10. The challenge of biotechnology.
Gore A; Owens S
Yale Law Policy Rev; 1985; 3(2):336-57. PubMed ID: 11652468
[No Abstract] [Full Text] [Related]
11. Proposals for the future regulation of biotechnology in Australia.
Neilson R
Melb Univ Law Rev; 1992 Jun; 18(3):692-8. PubMed ID: 11654325
[No Abstract] [Full Text] [Related]
12. The governance of human genetics: policy discourse and constructions of public trust.
Jones M; Salter B
New Genet Soc; 2003 Apr; 22(1):21-41. PubMed ID: 15282897
[TBL] [Abstract][Full Text] [Related]
13. The recombinant DNA controversy: twenty years later.
Berg P; Singer M
Biotechnology (N Y); 1995 Oct; 13(10):1132-4. PubMed ID: 11644758
[No Abstract] [Full Text] [Related]
14. State biotechnology oversight: the juncture of technology, law, and public policy.
Vito CC
Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701
[No Abstract] [Full Text] [Related]
15. Molecular biology or molecular politics? The production of scientific consensus on the hazards of recombinant DNA technology.
Wright S
Soc Stud Sci; 1986 Nov; 16(4):593-620. PubMed ID: 11650809
[No Abstract] [Full Text] [Related]
16. Genetics and the law: a scientist's view.
Singer MF
Yale Law Policy Rev; 1985; 3(2):315-35. PubMed ID: 11652467
[No Abstract] [Full Text] [Related]
17. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
Baark E; Jamison A
Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
[No Abstract] [Full Text] [Related]
18. Guess what's coming to dinner?
Vines G
New Sci; 1992 Nov; 136(1847):13-4. PubMed ID: 11656186
[No Abstract] [Full Text] [Related]
19. How to keep out what we don't want: an assessment of 'Sozialverträglichkeit' under the Austrian Genetic Engineering Act.
Seifert F; Torgersen H
Public Underst Sci; 1997 Oct; 6(4):301-27. PubMed ID: 11655383
[No Abstract] [Full Text] [Related]
20. Europe's ethics standards.
Nat Biotechnol; 1998 Dec; 16(13):1298. PubMed ID: 11645139
[No Abstract] [Full Text] [Related]
[Next] [New Search]